| Peripapillary retinal nerve fibre layer as measured by optical coherence tomography is a prognostic biomarker not only for physical but also for cognitive disability … G Bsteh, H Hegen, B Teuchner, M Amprosi, K Berek, F Ladstätter, S Wurth, ... Multiple Sclerosis Journal 25 (2), 196-203, 2019 | 86 | 2019 |
| Long term clinical prognostic factors in relapsing-remitting multiple sclerosis: insights from a 10-year observational study G Bsteh, R Ehling, A Lutterotti, H Hegen, F Di Pauli, M Auer, ... PloS one 11 (7), e0158978, 2016 | 84 | 2016 |
| Discontinuation of disease-modifying therapies in multiple sclerosis–clinical outcome and prognostic factors G Bsteh, J Feige, R Ehling, M Auer, H Hegen, F Di Pauli, ... Multiple Sclerosis Journal 23 (9), 1241-1248, 2017 | 80 | 2017 |
| ‘No evidence of disease activity’–is it an appropriate surrogate in multiple sclerosis? H Hegen, G Bsteh, T Berger European journal of neurology 25 (9), 1107-e101, 2018 | 68 | 2018 |
| Pregnancy and multiple sclerosis in the DMT era: a cohort study in Western Austria G Bsteh, L Algrang, H Hegen, M Auer, S Wurth, F Di Pauli, ... Multiple Sclerosis Journal 26 (1), 69-78, 2020 | 59 | 2020 |
| NMDA receptor antibodies: a rare association in inflammatory demyelinating diseases M Ramberger, G Bsteh, K Schanda, R Höftberger, K Rostásy, M Baumann, ... Neuroimmunology & Neuroinflammation 2 (5), e141, 2015 | 50 | 2015 |
| Multiple sclerosis and COVID‐19: how many are at risk? G Bsteh, C Bitschnau, H Hegen, M Auer, F Di Pauli, P Rommer, ... European journal of neurology 28 (10), 3369-3374, 2021 | 46 | 2021 |
| Serum neurofilament light chain withstands delayed freezing and repeated thawing P Altmann, F Leutmezer, H Zach, R Wurm, M Stattmann, M Ponleitner, ... Scientific reports 10 (1), 19982, 2020 | 42 | 2020 |
| Expansion of neutrophils and classical and nonclassical monocytes as a hallmark in relapsing-remitting multiple sclerosis D Haschka, P Tymoszuk, G Bsteh, V Petzer, K Berek, I Theurl, T Berger, ... Frontiers in Immunology 11, 594, 2020 | 42 | 2020 |
| Prognosis and prognostic factors in non‐traumatic acute‐onset compressive mononeuropathies–radial and peroneal mononeuropathies G Bsteh, JV Wanschitz, H Gruber, K Seppi, WN Löscher European journal of neurology 20 (6), 981-985, 2013 | 41 | 2013 |
| Macular ganglion cell–inner plexiform layer thinning as a biomarker of disability progression in relapsing multiple sclerosis G Bsteh, K Berek, H Hegen, P Altmann, S Wurth, M Auer, A Zinganell, ... Multiple Sclerosis Journal 27 (5), 684-694, 2021 | 40 | 2021 |
| Seven day pre-analytical stability of serum and plasma neurofilament light chain P Altmann, M Ponleitner, PS Rommer, H Haslacher, P Mucher, ... Scientific reports 11 (1), 11034, 2021 | 39 | 2021 |
| Kappa-free light chains in CSF predict early multiple sclerosis disease activity K Berek, G Bsteh, M Auer, F Di Pauli, A Grams, D Milosavljevic, ... Neurology: Neuroimmunology & Neuroinflammation 8 (4), e1005, 2021 | 37 | 2021 |
| B cell depletion and SARS‐CoV‐2 vaccine responses in neuroimmunologic patients B Kornek, F Leutmezer, PS Rommer, M Koblischke, L Schneider, ... Annals of Neurology 91 (3), 342-352, 2022 | 34 | 2022 |
| Peripapillary retinal nerve fibre layer thinning rate as a biomarker discriminating stable and progressing relapsing–remitting multiple sclerosis G Bsteh, H Hegen, B Teuchner, K Berek, S Wurth, M Auer, F Di Pauli, ... European Journal of Neurology 26 (6), 865-871, 2019 | 34 | 2019 |
| Change of olfactory function as a marker of inflammatory activity and disability progression in MS G Bsteh, H Hegen, F Ladstätter, K Berek, M Amprosi, S Wurth, M Auer, ... Multiple Sclerosis Journal 25 (2), 267-274, 2019 | 34 | 2019 |
| Stability and predictive value of anti-JCV antibody index in multiple sclerosis: A 6-year longitudinal study H Hegen, M Auer, G Bsteh, F Di Pauli, T Plavina, J Walde, ... PLoS One 12 (3), e0174005, 2017 | 34 | 2017 |
| Serum neurofilament levels correlate with retinal nerve fiber layer thinning in multiple sclerosis G Bsteh, K Berek, H Hegen, B Teuchner, A Buchmann, MM Voortman, ... Multiple Sclerosis Journal 26 (13), 1682-1690, 2020 | 33 | 2020 |
| COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry G Bsteh, H Assar, H Hegen, B Heschl, F Leutmezer, F Di Pauli, C Gradl, ... PLoS One 16 (7), e0255316, 2021 | 29 | 2021 |
| Monoclonal antibodies in the treatment of relapsing multiple sclerosis: an overview with emphasis on pregnancy, vaccination, and risk management N Krajnc, G Bsteh, T Berger, J Mares, HP Hartung Neurotherapeutics 19 (3), 753-773, 2022 | 27 | 2022 |
